Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +1.06% to 9751.31, DAX +0.18% to 24229.91, CAC40 +0.70% to 8124.88, STOXX 600 +0.74% to 582.54

Dec 15 ,2025

  • Synopsis:

    • European equity markets closed higher with UK closing near session highs. Follows last week's softer performance. Banks, travel/leisure and insurance were the best performers. Autos, real estate and retail lagged.

    • Nothing incremental for European markets after coming under pressure late Friday and ending week lower. Markets keying off better US sentiment. Note, tech remained a focal point overnight with weakness the big story in key Asian markets amid a selloff in chip stocks. Concerns revolve around intertwined risks on infrastructure/debt/ROI/OpenAI.

    • Focus to turn to central bank updates this week with four policy decisions in Europe, including the ECB and the BoE. The BoE is the only central bank in region tipped to cut rates.

    • Macro data in Europe includes firmer German wholesale prices and Eurozone industrial production saw strongest performance in five months in October. Survey on latest UK labor market developments from REC showed job listings fell for second month in a row. Update from property portal Rightmove highlights slowdown in UK housing market into year-end.

    • Elsewhere, European leaders to decide on loans to Ukraine as peace talks continue in the background. Ukraine President Zelensky dropped Nato membership ambitions in exchange for security guarantees.

    • In M&A news, Orange (ORA.FP) announced a binding agreement with Lorca to acquire their 50% stake in MasOrange for €4.25B in cash whilst - still in France - Carrefour (CA.FP) sold four more hypermarkets in Spain to a US buyer, local press reported. In Spain, ACCIONA Energía (ANE.SM) sold a 49% stake in a 1.3GW photovoltaic portfolio in the US and its full stake in two wind farms in Mexico for ~$1B. In the UK, Next (NXT.LN) is reportedly among few suitors for Russell & Bromley and - in the Nordics - Sobi (SOBI.SS) entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc.

    • Elsewhere, Hikma Pharmaceuticals (HIK.LN) CEO stepped down and the UK's FRC commences investigation in relation to statutory audit by Ernst & Young of consolidated financial statements of Shell (SHEL.LN) for the financial year ended 31-Dec-24.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Banks +1.69%, Travel & Leisure +1.13%, Insurance +1.10%, Construct & Mtls +1.09%, Utilities +0.96%, Food & Beverage +0.94%, Basic Resources +0.89%

      • Underperformers:

        • Autos & Parts (0.26%), Real Estate (0.13%), Retail (0.08%), Chemicals +0.12%, Telecom +0.18%, Oil & Gas +0.28%, Media +0.34%, Health Care +0.38%, Technology +0.40%, Persnl & HHold Goods +0.64%, Financial Svcs +0.64%, Ind Goods & Svcs +0.66%

    • Peripheral markets:

      • Geopolitics:

        • Zelensky offers to drop NATO membership bid as Trump envoy seeks progress in peace talks - France24

        • EU's von der Leyen, NATO's Rutte join Ukraine talks in Berlin - Reuters

        • EU approves extending freeze on Russian assets to help Ukraine war effort - Bloomberg

        • France and Italy aligned on need to delay final Mercosur vote, say sources - Reuters

      • France:

        • French senators approve 2026 budget bill - Reuters

      • UK:

        • Business groups urge peers to pass UK employment rights bill - FT

        • Bank of England set to cut rates to 3.75% as economic data eases inflation concerns - FT

        • UK labor market weakened further into the year end survey shows - Recruitment and Confederation release

        • Rightmove forecasts UK new seller asking prices +2% y/y in 2026 - release

        • UK Finance mortgage market forecasts 2026 - Property Industry Eye

        • Policy makers need to focus on forgotten driver of Britain's jobs downturn - rising unemployment - Resolution Foundation

      • Switzerland:

        • SECO forecasts Swiss 2026 GDP +0.9% vs prior estimate +1.5%, downside risks currently dominate - release

    • Company news:

      • Notable Gainers

        • +23.6% TOBII.SS (Tobii SEK1.90, +0.36) -- DMS licensing deal

        • +18.5% JUVE.IM (Juventus Football Club €2.60, +0.41) -- Tether submits proposal to acquire Juventus Football Club; Exor board unanimously rejects Tether's unsolicited proposal to acquire Juventus

        • +10.5% CHAR.LN (Chariot £0.02, -0.00) -- financing completed for South Africa Wind Projects

        • +9.0% FRAS.LN (Frasers Group £6.86, +0.57) -- buyback

        • +4.1% BIOVIC.B.SS (Biovica International SEK0.56, +0.02) -- commercial client agreement

        • +3.3% PLNW.FP (Planisware €21.80, +0.70) -- initiated buy at Kepler Cheuvreux

        • +3.1% BKS.LN (Beeks Financial Cloud Group £2.50, +0.08) -- contract

        • +2.5% EZE.SM (Grupo Ezentis €0.09, -0.00) -- contract

        • +2.5% HBMN.SW (HBM Healthcare Investments CHF224.50, +5.50) -- to sell majority stake in Swixx Biopharma to SK Capital Partners

        • +2.3% BPT.LN (Bridgepoint Group £2.85, +0.06) -- Deutsche Numis upgrade

        • +1.9% VK.FP (Vallourec €15.75, +0.30) -- initiated buy at Goldman Sachs

        • +1.6% NESTE.FH (Neste €18.60, +0.29) -- Berenberg upgrade; revises some climate targets

        • +1.5% SFL.IM (Safilo Group €1.94, +0.03) -- confirms that it does not intend to make a firm offer for Inspecs

      • Notable Decliners

        • -20.9% TRUE.B.SS (Truecaller SEK18.10, -4.78) -- profit warning

        • -19.6% TTG.LN (TT Electronics £1.06, -0.26) -- DBAY confirms that it does not intend to make offer for TT Electronics

        • -10.8% SWTQ.SW (Schweiter Technologies CHF248.00, -30.00) -- prelim sales

        • -6.5% HUBN.SW (HUBER+SUHNER CHF144.00, -10.00) -- profit warning

        • -5.7% DOCM.SW (DocMorris CHF5.57, -0.34) -- competitor dm to launch own online pharmacy on this week

        • -3.9% HNSA.SS (Hansa Biopharma SEK34.50, -1.40) -- reorganization of its European and International Commercial and Medical Affairs operations

        • -3.9% TNOM.FH (Talenom €3.07, -0.13) -- profit warning

        • -3.8% CICN.SW (Cicor Technologies CHF125.50, -5.00) -- DBAY confirms that it does not intend to make offer for TT Electronics

        • -3.3% SAN.FP (Sanofi €80.60, -2.72) -- update on tolebrutinib regulatory submission

        • -3.0% DBV.FP (DBV Technologies €3.13, -0.10) -- initiated overweight at Cantor Fitzgerald

        • -1.7% SOBI.SS (Swedish Orphan Biovitrum SEK324.00, -5.60) -- acquisition

    • EU companies reporting tomorrow:

      • Earnings:

        • Nordics: Per Aarsleff Holding (PAAL.B.DC)

        • UK: Hollywood Bowl Group (BOWL.LN)

      • Trading Update:

        • UK: Sthree (STEM.LN)

      • Traffic: Aeroport de Paris (ADP.FP), Flughafen Wien (FLU.AV), VINCI (DG.FP)

      • EGM: Mendus (IMMU.SS), BE Group (BERG.SS), ACOMO (ACOMO.NA)

      • CMD/Events: Novonesis (NSIS.B.DC) spotlight educational session on Dairy (webcast)

  • Data:

    • Economics:

      • UK Dec house price index (0.6%) y/y vs prior (0.5%) - Rightmove

      • Finland Nov CPI (0.1%) y/y vs consensus (0.1%), prior (0.2%)

      • Norway Nov trade balance NOK41.3B vs consensus NOK45.1B, prior revised NOK56.1B from NOK56.5B

      • Switzerland Oct PPI (1.6%) y/y vs consensus (1.9%), prior (1.7%)

      • Eurozone Oct +2.0% y/y vs consensus +1.9%, prior +1.2%

    • Markets:

      • WTI Crude (Jan 26): ($0.78) or (1.36%) to $56.66

      • €-$ +0.0015 or +0.13% to 1.1754

      • £-$ +0.0005 or +0.04% to 1.3378

      • €-£ +0.0011 to 0.8789

      • S&P 500 (0.16%)

      • Performance year-to-date

        • FTSE 100: +19.31%

        • DAX: +21.70%

        • CAC: +10.08%

        • MIB: +29.05%

        • Stoxx 600: +14.76%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE